New data indicates substantial disruptions to HIV treatment and prevention programs funded by the President’s Emergency Plan for AIDS Relief (PEPFAR) following a foreign aid overhaul initiated in January 2025. These changes have raised concerns about the future of global HIV/AIDS efforts.

Clinic Disruptions and Data Transparency

A vital clinic in Kitwe, Zambia, previously supported by PEPFAR, once provided essential medications to individuals living with HIV. Operations at this facility, and numerous others, have faced significant disruption after the aid overhaul. For years, PEPFAR maintained a commitment to transparency, releasing comprehensive data four times annually.

This regular reporting allowed global health experts to track the program’s progress and assess its effectiveness. However, this consistent flow of information has ceased, leaving specialists in the global health community awaiting official data releases.

Conflicting Reports and Independent Assessments

Government officials have attempted to portray a positive outlook, citing the number of individuals receiving HIV treatment as evidence of continued success. The acting undersecretary of state for foreign assistance, humanitarian affairs, and religious freedom recently stated that observers would be surprised by the resilience of U.S. health programs.

However, independent assessments paint a more concerning picture. The Foundation for AIDS Research (amfAR), in collaboration with experts from the International AIDS Society, has identified “substantial disruptions across PEPFAR service areas,” characterizing the situation as “a troubling inflection point.”

According to a deputy director of public policy at amfAR, the data presented by the State Department deliberately “obscures the true damage of the interruptions.”

Data Reveals Alarming Trends

PEPFAR has long been recognized for its exceptional data quality, providing detailed quarterly reports focused on U.S.-funded initiatives. Experts emphasize that the program’s success stemmed from its investment in a robust and accountable data system.

While Trump administration officials highlight progress in ending mother-to-child transmission of HIV – noting an increase in pregnant and breastfeeding women starting PrEP from 43,000 to 103,000 between the final quarters of 2024 and 2025 – critics argue this focus distracts from the broader negative impacts of the aid cuts.

The administration also points to the fact that the U.S. continued to support HIV treatment for over 20 million people across 50 countries as of the end of September last year, a figure representing only a slight decrease compared to the previous year.

Impact on HIV Diagnoses and Healthcare Workers

However, this limited decline masks a more alarming trend. Russell stated that “For the first time in history, PEPFAR has put fewer people on therapy than the year before. That is an absolute indictment of this administration.”

Honermann of amfAR further elaborates that the data reveals a severe compromise of the system in place for preventing and addressing HIV cases. Approximately 24% of frontline healthcare workers have lost their support and employment as programs deemed non-life-saving were eliminated.

In PEPFAR-funded clinics and treatment centers unaffected by the aid cuts, the diagnosis of new HIV cases decreased by 13%. However, in areas where services were interrupted, the decline in diagnoses reached nearly 30%. This translates to “hundreds of thousands of people that we would have expected to see get their diagnoses and get put under treatment – and those people are now just missing.”

State Department Response

The State Department asserts that “the message is clear: we cut overall spending by 30 percent while preserving critical frontline HIV care and eliminating wasteful programs. This proves the America First Global Health Strategy works.” However, independent analysis suggests a far more complex and troubling reality.